OXAliplatin

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17417 publications

Natural melanin nanoparticles modified with glycol chitosan for enhanced delivery of oxaliplatin.

Natural melanin nanoparticles modified with glycol chitosan for enhanced delivery of oxaliplatin.

Journal: Journal of biomaterials applications

Published: June 19, 2026

Adjuvant Chemoradiotherapy or Chemotherapy After D2 Gastrectomy in Gastric Cancer: A Randomized Clinical Trial.

Adjuvant Chemoradiotherapy or Chemotherapy After D2 Gastrectomy in Gastric Cancer: A Randomized Clinical Trial.

Journal: JAMA network open

Published: June 15, 2026

Ultrasonographic assessment of chemotherapy-induced peripheral neuropathy after oxaliplatin treatment: an exploratory study.

Ultrasonographic assessment of chemotherapy-induced peripheral neuropathy after oxaliplatin treatment: an exploratory study.

Journal: Acta radiologica (Stockholm, Sweden : 1987)

Published: June 05, 2026

HPLC-HRMS determination of anticancer drugs and their degradants identified by heterogeneous photocatalysis as potential river toxicants.

HPLC-HRMS determination of anticancer drugs and their degradants identified by heterogeneous photocatalysis as potential river toxicants.

Journal: European journal of mass spectrometry (Chichester, England)

Published: June 01, 2026

Localized Depletion of Macrophages by Abdominal Cavity Retention Nanoparticles as a Potential Therapy for Peritoneal Metastasis.

Localized Depletion of Macrophages by Abdominal Cavity Retention Nanoparticles as a Potential Therapy for Peritoneal Metastasis.

Journal: ACS nano

Published: June 01, 2026

Quantification of oxaliplatin and lansoprazole in tumor tissue homogenates by LC-MS/MS: a fit-for-purpose bioanalytical approach.

Quantification of oxaliplatin and lansoprazole in tumor tissue homogenates by LC-MS/MS: a fit-for-purpose bioanalytical approach.

Journal: Bioanalysis

Published: May 29, 2026

Ethanol promotes oxaliplatin resistance in colorectal cancer by activating the TGF‑β/Smad/P21 signaling axis

Ethanol promotes oxaliplatin resistance in colorectal cancer by activating the TGF‑β/Smad/P21 signaling axis

Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University

Published: May 27, 2026

A Case of Recurrent Esophagogastric Junction Cancer with Long‒Term Complete Response by Trastuzumab Deruxtecan

A Case of Recurrent Esophagogastric Junction Cancer with Long‒Term Complete Response by Trastuzumab Deruxtecan

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: May 25, 2026

Severe Hyperammonemic Encephalopathy Associated With Gastrointestinal Bleeding During Capecitabine and Oxaliplatin Chemotherapy in a Patient With Rectal Adenocarcinoma.

Severe Hyperammonemic Encephalopathy Associated With Gastrointestinal Bleeding During Capecitabine and Oxaliplatin Chemotherapy in a Patient With Rectal Adenocarcinoma.

Journal: Cureus

Published: May 22, 2026

Statement of Retraction: WD repeat domain 62 (WDR62) promotes resistance of colorectal cancer to oxaliplatin through modulating mitogen-activated protein kinase (MAPK) signaling.

Statement of Retraction: WD repeat domain 62 (WDR62) promotes resistance of colorectal cancer to oxaliplatin through modulating mitogen-activated protein kinase (MAPK) signaling.

Journal: Bioengineered

Published: May 21, 2026

Autophagy-Enhanced Nanoplatforms Eliminate Intracellular Bacteria and Block Bacteria-Driven Epithelial-Mesenchymal Transition for Tumor Metastasis Inhibition.

Autophagy-Enhanced Nanoplatforms Eliminate Intracellular Bacteria and Block Bacteria-Driven Epithelial-Mesenchymal Transition for Tumor Metastasis Inhibition.

Journal: ACS nano

Published: May 20, 2026

Expert consensus on the clinical application of the Chinese-modified triplet combination with irinotecan, oxaliplatin and continuous infusional 5-fluorouracil / leucovorin for colorectal cancer (2026 edition)

Expert consensus on the clinical application of the Chinese-modified triplet combination with irinotecan, oxaliplatin and continuous infusional 5-fluorouracil / leucovorin for colorectal cancer (2026 edition)

Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery

Published: May 20, 2026

Showing 1-12 of 17,417

Last Updated: 06/30/2026